|
RNF34 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.3262000043166E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.2583000000308E-06 |
| Normal-vs-Stage2 |
1.290160E-02 |
| Normal-vs-Stage3 |
5.064700E-03 |
| Normal-vs-Stage4 |
1.789410E-01 |
| Stage1-vs-Stage2 |
9.287400E-01 |
| Stage1-vs-Stage3 |
9.339000E-01 |
| Stage1-vs-Stage4 |
5.384800E-01 |
| Stage2-vs-Stage3 |
8.871800E-01 |
| Stage2-vs-Stage4 |
5.353400E-01 |
| Stage3-vs-Stage4 |
5.808800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11449999995461E-06 |
| Normal-vs-AfricanAmerican |
1.70219999995336E-06 |
| Normal-vs-Asian |
5.573900E-02 |
| Caucasian-vs-AfricanAmerican |
1.044380E-01 |
| Caucasian-vs-Asian |
3.040800E-01 |
| AfricanAmerican-vs-Asian |
6.904400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.05390000007633E-07 |
| Normal-vs-Female |
1.03470000001327E-06 |
| Male-vs-Female |
4.291000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.903500E-03 |
| Normal-vs-Extreme_Weight |
1.097770E-03 |
| Normal-vs-Obese |
2.1780999999943E-05 |
| Normal-vs-Extreme_Obese |
2.206200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.433600E-01 |
| Normal_Weight-vs-Obese |
1.571020E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.953400E-01 |
| Extreme_Weight-vs-Obese |
1.141200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.644200E-01 |
| Obese-vs-Extreme_Obese |
4.363400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.87489999876101E-08 |
| Normal-vs-Age(41-60Yrs) |
1.18099999779631E-08 |
| Normal-vs-Age(61-80Yrs) |
4.08990000000387E-05 |
| Normal-vs-Age(81-100Yrs) |
5.469600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.373770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.436210E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.422400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.594250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.855900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.266000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.10540029854656E-10 |
| Normal-VS-Type2 PRCC |
2.222200E-01 |
| Normal-VS-KIRP CIMP |
3.664900E-03 |
| Normal-VS-Unclassified PRCC |
2.813200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.4741999999911E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.263200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.458000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.882610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.117000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.430200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.814190E-02 |
| Normal-vs-N1 |
4.280100E-03 |
| Normal-vs-N2 |
4.886200E-01 |
| N0-vs-N1 |
7.805700E-02 |
| N0-vs-N2 |
6.760800E-01 |
| N1-vs-N2 |
3.157600E-01 |
|
|
